Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2005 4
2006 3
2007 7
2008 5
2009 3
2010 7
2011 13
2012 12
2013 13
2014 14
2015 19
2016 12
2017 8
2018 10
2019 4
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 24403454

126 results
Results by year
Filters applied: . Clear all
Page 1
Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.
Suenaga S, Kuramitsu Y, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K. Suenaga S, et al. Anticancer Res. 2014 Jan;34(1):141-6. Anticancer Res. 2014. PMID: 24403454
Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
Tokunaga M, Baron B, Kitagawa T, Tokuda K, Kuramitsu Y. Tokunaga M, et al. Anticancer Res. 2015 Nov;35(11):6063-7. Anticancer Res. 2015. PMID: 26504030
Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells.
Nawata J, Kuramitsu Y, Wang Y, Kitagawa T, Tokuda K, Baron B, Akada J, Suenaga S, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K. Nawata J, et al. Anticancer Res. 2014 Sep;34(9):4807-11. Anticancer Res. 2014. PMID: 25202061
CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells.
Kuhara K, Tokuda K, Kitagawa T, Baron B, Tokunaga M, Harada K, Terasaki M, Uehara O, Ohta T, Takai R, Hamada JI, Kobayashi M, Shimo T, Nagayasu H, Kuramitsu Y. Kuhara K, et al. Anticancer Res. 2018 Nov;38(11):6107-6111. doi: 10.21873/anticanres.12961. Anticancer Res. 2018. PMID: 30396925
KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.
Taba K, Kuramitsu Y, Ryozawa S, Yoshida K, Tanaka T, Mori-Iwamoto S, Maehara S, Maehara Y, Sakaida I, Nakamura K. Taba K, et al. Chemotherapy. 2011;57(1):12-6. doi: 10.1159/000321019. Epub 2010 Dec 3. Chemotherapy. 2011. PMID: 21124027
Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.
Taba K, Kuramitsu Y, Ryozawa S, Yoshida K, Tanaka T, Maehara S, Maehara Y, Sakaida I, Nakamura K. Taba K, et al. Anticancer Res. 2010 Jul;30(7):2539-43. Anticancer Res. 2010. PMID: 20682980
Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.
Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, Mikuria K, Fujimoto M, Maehara S, Maehara Y, Okita K, Nakamura K, Sakaida I. Mori-Iwamoto S, et al. Int J Oncol. 2007 Dec;31(6):1345-50. Int J Oncol. 2007. PMID: 17982661
Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells.
Nakashima M, Adachi S, Yasuda I, Yamauchi T, Kawaguchi J, Itani M, Yoshioka T, Matsushima-Nishiwaki R, Hirose Y, Kozawa O, Moriwaki H. Nakashima M, et al. Cancer Lett. 2011 Dec 27;313(2):218-25. doi: 10.1016/j.canlet.2011.09.008. Epub 2011 Sep 17. Cancer Lett. 2011. PMID: 21999932
Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells.
Suenaga S, Kuramitsu Y, Wang Y, Baron B, Kitagawa T, Akada J, Tokuda K, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K. Suenaga S, et al. Anticancer Res. 2013 Nov;33(11):4821-6. Anticancer Res. 2013. PMID: 24222118
Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells.
Kuramitsu Y, Suenaga S, Wang Y, Tokuda K, Kitagawa T, Tanaka T, Akada J, Maehara S, Maehara Y, Nakamura K. Kuramitsu Y, et al. Anticancer Res. 2013 Aug;33(8):3133-6. Anticancer Res. 2013. PMID: 23898070
126 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page